Highly Anticipated Drugs From BioSante and AEterna Zentaris May Not Be as...
NEW YORK, NY– – Shares throughout the biotechnology sector have been exceptionally volatile of late as developments regarding government approvals, litigation and shockingly disappointing earnings...
View ArticleCancer Treatments From Dendreon and Cell Therapeutics May Not Be as Lucrative...
NEW YORK, NY– – Shares throughout the biotechnology sector have been exceptionally volatile of late as developments regarding government approvals, litigation and shockingly disappointing earnings...
View ArticleChemistry Information Centre Berlin (FIZ CHEMIE) Up For Sale
The public sector shareholders of Berlin's Chemistry Information Centre FIZ CHEMIE GmbH are putting their shares up for sale. It provides chemical data and abstracts for scientific and industrial...
View ArticleOsiris stem-cell therapy wins Canadian approval
BOSTON (MarketWatch) — Shares of Osiris Therapeutics jumped 14% to $5.60 in after-hours trading Thursday on news that Canadian regulators have approved its product Prochymal for the treatment of acute...
View ArticlePluristem shares bounce back after Thursday plunge
NEW YORK (AP) Shares of biotechnology company Pluristem Therapeutics Inc. bounced back Friday after the company responded to a report that a patient treated with its PLX stem cell therapy had died....
View ArticleCNSE Shares Nano-Opportunities With Children as Part of NANOvember’s Nano...
www.youtube.com/watch?v=tb2X-Jqk-AkCNSE Shares Nano-Opportunities With Children as Part of NANOvember's Nano Discovery ProgramMore than 100 elementary and middle-school students in Albany explored the...
View Article
More Pages to Explore .....